Rachael Atlee Akron Bio

Rachael Atlee is Vice President of Operations at Akron Bio, a leading innovator in ancillary materials to support cell and gene therapy products. With over 20 years in biopharmaceutical operations at Merck, Bristol Myers Squibb, and Akron Bio, she has led transformative initiatives in vaccines, parenterals and ATMPs. Her work has accelerated time-to-market for critical therapies and strengthened global manufacturing capabilities. Rachael brings deep expertise in GMP compliance, lean systems, and operational scale-up for advanced therapies.